Skip to main content
Premium Trial:

Request an Annual Quote

IDBS Leads Consortium Building Platform for Stratified, Translational Medicine

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – IDBS today announced that it is developing an informatics platform to support stratified and translational medicine research and cross-organization collaboration.

The UK-based data management, analytics, and solutions firm was chosen by the Technology Strategy Board for the project, and will head a consortium called Tumor Profiling and Data Capture. Hosting firm Quantix and cancer centers at Kings Health Partners and Manchester Academic Health Science Center are also part of the consortium.

The platform being developed, called Advanced Collaborative Research for Oncology Platform for Improved Outcomes, Learnings, Insight, and Sciencer( ACROPOLIS), will provide a cancer informatics infrastructure to support secure stratified medicine research and collaboration, including data handling, storage, retrieval, and analysis services.

According to IDBS, ACROPOLIS will enable medical centers, pharmaceutical research, diagnostic companies, and other health science organizations to identify patient populations and better understand the genetics of cancer.

The consortium is being provided £3 million ($4.9 million) in funding, half from the Technology Strategy Board, as part of the UK's Stratified Medicines Innovation Platform (SMIP), and half from commercial partners.

The advisory board for the ACROPOLIS project includes Peter Parker, head of cancer studies at King's College London; Tony Whetton, head of cancer and enabling sciences at Manchester University; and representatives from Quantix, Roche Pharmaceutical, Cancer Research UK, PA Consulting, and the National Institute of Health Research.

"This innovative platform will put translational research activities onto another level, providing unprecedented opportunities to collaborate between organizations, and ultimately leading to improved treatments across global healthcare systems," Parker said in a statement.

The Scan

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.

Study Explores Animated Digital Message Approach to Communicate Genetic Test Results to Family Members

In the Journal of Genetic Counseling, the approach showed promise in participants presented with a hypothetical scenario related to a familial hereditary breast and ovarian cancer syndrome diagnosis.

Computational Tool Predicts Mammalian Messenger RNA Degradation Rates

A tool called Saluki, trained with mouse and human messenger RNA data, appears to improve mRNA half-life predictions by taking RNA and genetic features into account, a Genome Biology paper reports.

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.